ONTOLOGY,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
BP,GO:0007596,blood coagulation,12/85,168/23355,1.08E-12,8.92E-10,6.21E-10,F9/Fga/Fgb/Fgg/Gp5/Mmrn1/Pf4/Ppia/Prdx2/Slc4a1/Thbs1/Vwf,12
BP,GO:0007599,hemostasis,12/85,170/23355,1.24E-12,8.92E-10,6.21E-10,F9/Fga/Fgb/Fgg/Gp5/Mmrn1/Pf4/Ppia/Prdx2/Slc4a1/Thbs1/Vwf,12
BP,GO:0050817,coagulation,12/85,171/23355,1.33E-12,8.92E-10,6.21E-10,F9/Fga/Fgb/Fgg/Gp5/Mmrn1/Pf4/Ppia/Prdx2/Slc4a1/Thbs1/Vwf,12
BP,GO:0042744,hydrogen peroxide catabolic process,7/85,28/23355,7.31E-12,3.68E-09,2.56E-09,Gpx1/Hbq1b/Hp/Prdx1/Prdx2/Prdx6/Snca,7
BP,GO:0042060,wound healing,14/85,357/23355,4.21E-11,1.69E-08,1.18E-08,F9/Fga/Fgb/Fgg/Gp5/Gpx1/Krt6a/Mmrn1/Pf4/Ppia/Prdx2/Slc4a1/Thbs1/Vwf,14
BP,GO:0006979,response to oxidative stress,14/85,410/23355,2.59E-10,8.70E-08,6.05E-08,Aldh1a1/Capn1/Cfl1/Cst3/Gpx1/Hp/Ppia/Prdx1/Prdx2/Prdx6/Slc4a1/Snca/Thbs1/Txnrd2,14
BP,GO:0050878,regulation of body fluid levels,13/85,360/23355,6.08E-10,1.75E-07,1.22E-07,F9/Fga/Fgb/Fgg/Gp5/Mmrn1/Nme1/Pf4/Ppia/Prdx2/Slc4a1/Thbs1/Vwf,13
BP,GO:0019693,ribose phosphate metabolic process,13/85,365/23355,7.19E-10,1.81E-07,1.26E-07,Atic/Bpgm/Eno1/Gda/Nme1/Pnp/Rhoa/Rpia/Slc4a1/Snca/Tkt/Tpi1/Vcp,13
BP,GO:0042743,hydrogen peroxide metabolic process,7/85,55/23355,1.16E-09,2.59E-07,1.80E-07,Gpx1/Hbq1b/Hp/Prdx1/Prdx2/Prdx6/Snca,7
BP,GO:0000302,response to reactive oxygen species,10/85,200/23355,3.03E-09,6.10E-07,4.25E-07,Capn1/Cfl1/Gpx1/Hp/Prdx1/Prdx2/Prdx6/Slc4a1/Thbs1/Txnrd2,10
BP,GO:0051258,protein polymerization,11/85,295/23355,1.01E-08,1.85E-06,1.29E-06,Capn1/Cfl1/Fga/Fgb/Fgg/Gda/Pfn1/Rhoa/Snca/Spta1/Sptb,11
BP,GO:0072593,reactive oxygen species metabolic process,11/85,301/23355,1.24E-08,2.08E-06,1.45E-06,Eef1a1/Eif5a/Gpx1/Hbq1b/Hp/Prdx1/Prdx2/Prdx6/Rhoa/Snca/Thbs1,11
BP,GO:0030168,platelet activation,7/85,85/23355,2.58E-08,3.99E-06,2.78E-06,Fga/Fgb/Fgg/Gp5/Pf4/Ppia/Vwf,7
BP,GO:0006959,humoral immune response,12/85,407/23355,2.79E-08,4.01E-06,2.79E-06,Fga/Fgb/Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Krt6a/Ltf/Pf4/Ppbp,12
BP,GO:0009150,purine ribonucleotide metabolic process,11/85,335/23355,3.72E-08,4.99E-06,3.47E-06,Atic/Bpgm/Eno1/Gda/Nme1/Pnp/Rhoa/Slc4a1/Snca/Tpi1/Vcp,11
BP,GO:0099024,plasma membrane invagination,9/85,206/23355,6.26E-08,7.71E-06,5.37E-06,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Lbp/Rhoa/Thbs1,9
BP,GO:0009259,ribonucleotide metabolic process,11/85,354/23355,6.52E-08,7.71E-06,5.37E-06,Atic/Bpgm/Eno1/Gda/Nme1/Pnp/Rhoa/Slc4a1/Snca/Tpi1/Vcp,11
BP,GO:0006163,purine nucleotide metabolic process,11/85,360/23355,7.72E-08,8.63E-06,6.01E-06,Atic/Bpgm/Eno1/Gda/Nme1/Pnp/Rhoa/Slc4a1/Snca/Tpi1/Vcp,11
BP,GO:0010324,membrane invagination,9/85,213/23355,8.33E-08,8.82E-06,6.14E-06,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Lbp/Rhoa/Thbs1,9
BP,GO:0042742,defense response to bacterium,12/85,466/23355,1.22E-07,1.22E-05,8.53E-06,Fga/Fgb/Hp/Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Krt6a/Lbp/Ltf,12
BP,GO:0072521,purine-containing compound metabolic process,11/85,381/23355,1.37E-07,1.31E-05,9.11E-06,Atic/Bpgm/Eno1/Gda/Nme1/Pnp/Rhoa/Slc4a1/Snca/Tpi1/Vcp,11
BP,GO:0030193,regulation of blood coagulation,6/85,66/23355,1.48E-07,1.35E-05,9.43E-06,Fga/Fgb/Fgg/Gp5/Prdx2/Thbs1,6
BP,GO:1900046,regulation of hemostasis,6/85,67/23355,1.62E-07,1.37E-05,9.55E-06,Fga/Fgb/Fgg/Gp5/Prdx2/Thbs1,6
BP,GO:0002696,positive regulation of leukocyte activation,12/85,479/23355,1.64E-07,1.37E-05,9.55E-06,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Lbp/Pnp/Rhoa/Slc4a1/Spta1/Thbs1,12
BP,GO:0031638,zymogen activation,6/85,69/23355,1.94E-07,1.56E-05,1.09E-05,F9/Fga/Fgb/Fgg/Hp/Thbs1,6
BP,GO:0050818,regulation of coagulation,6/85,70/23355,2.11E-07,1.64E-05,1.14E-05,Fga/Fgb/Fgg/Gp5/Prdx2/Thbs1,6
BP,GO:0050867,positive regulation of cell activation,12/85,494/23355,2.28E-07,1.70E-05,1.18E-05,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Lbp/Pnp/Rhoa/Slc4a1/Spta1/Thbs1,12
BP,GO:0071621,granulocyte chemotaxis,7/85,126/23355,3.92E-07,2.81E-05,1.96E-05,Ccl8/Lbp/Pf4/Ppbp/Ppia/Thbs1/Thbs4,7
BP,GO:0009117,nucleotide metabolic process,11/85,440/23355,5.71E-07,3.74E-05,2.60E-05,Atic/Bpgm/Eno1/Gda/Nme1/Pnp/Rhoa/Slc4a1/Snca/Tpi1/Vcp,11
BP,GO:0032272,negative regulation of protein polymerization,6/85,83/23355,5.86E-07,3.74E-05,2.60E-05,Capn1/Cfl1/Pfn1/Snca/Spta1/Sptb,6
BP,GO:0045785,positive regulation of cell adhesion,11/85,442/23355,5.97E-07,3.74E-05,2.60E-05,Capn1/Cfl1/Enpp2/Fga/Fgb/Fgg/Pnp/Rhoa/Slc4a1/Spta1/Thbs1,11
BP,GO:0042730,fibrinolysis,4/85,19/23355,6.07E-07,3.74E-05,2.60E-05,Fga/Fgb/Fgg/Thbs1,4
BP,GO:0006911,"phagocytosis, engulfment",8/85,197/23355,6.14E-07,3.74E-05,2.60E-05,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Lbp/Thbs1,8
BP,GO:0006753,nucleoside phosphate metabolic process,11/85,449/23355,6.97E-07,4.12E-05,2.87E-05,Atic/Bpgm/Eno1/Gda/Nme1/Pnp/Rhoa/Slc4a1/Snca/Tpi1/Vcp,11
BP,GO:0050900,leukocyte migration,10/85,364/23355,8.29E-07,4.76E-05,3.32E-05,Capn1/Ccl8/Lbp/Pf4/Ppbp/Ppia/Retnlg/Rhoa/Thbs1/Thbs4,10
BP,GO:0030195,negative regulation of blood coagulation,5/85,48/23355,8.58E-07,4.79E-05,3.34E-05,Fga/Fgb/Fgg/Gp5/Thbs1,5
BP,GO:1900047,negative regulation of hemostasis,5/85,49/23355,9.53E-07,5.04E-05,3.51E-05,Fga/Fgb/Fgg/Gp5/Thbs1,5
BP,GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,5/85,49/23355,9.53E-07,5.04E-05,3.51E-05,Fga/Fgb/Fgg/Gpx1/Thbs1,5
BP,GO:0050819,negative regulation of coagulation,5/85,50/23355,1.06E-06,5.44E-05,3.79E-05,Fga/Fgb/Fgg/Gp5/Thbs1,5
BP,GO:0007160,cell-matrix adhesion,8/85,218/23355,1.32E-06,6.62E-05,4.61E-05,Cfl1/Enpp2/Fga/Fgb/Fgg/Gp5/Rhoa/Thbs1,8
BP,GO:0030595,leukocyte chemotaxis,8/85,220/23355,1.41E-06,6.91E-05,4.81E-05,Ccl8/Lbp/Pf4/Ppbp/Ppia/Retnlg/Thbs1/Thbs4,8
BP,GO:0097529,myeloid leukocyte migration,8/85,221/23355,1.46E-06,6.98E-05,4.86E-05,Ccl8/Lbp/Pf4/Ppbp/Ppia/Retnlg/Thbs1/Thbs4,8
BP,GO:0097530,granulocyte migration,7/85,155/23355,1.58E-06,7.37E-05,5.13E-05,Ccl8/Lbp/Pf4/Ppbp/Ppia/Thbs1/Thbs4,7
BP,GO:0031639,plasminogen activation,4/85,24/23355,1.64E-06,7.37E-05,5.13E-05,Fga/Fgb/Fgg/Thbs1,4
BP,GO:0060326,cell chemotaxis,9/85,304/23355,1.65E-06,7.37E-05,5.13E-05,Ccl8/Enpp2/Lbp/Pf4/Ppbp/Ppia/Retnlg/Thbs1/Thbs4,9
BP,GO:0032271,regulation of protein polymerization,8/85,228/23355,1.84E-06,7.83E-05,5.45E-05,Capn1/Cfl1/Gda/Pfn1/Rhoa/Snca/Spta1/Sptb,8
BP,GO:0030593,neutrophil chemotaxis,6/85,101/23355,1.87E-06,7.83E-05,5.45E-05,Ccl8/Lbp/Pf4/Ppbp/Ppia/Thbs4,6
BP,GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,6/85,101/23355,1.87E-06,7.83E-05,5.45E-05,Fga/Fgb/Fgg/Gpx1/Pf4/Prdx2,6
BP,GO:0006091,generation of precursor metabolites and energy,10/85,404/23355,2.12E-06,8.69E-05,6.05E-05,Bpgm/Eno1/Ldha/Rhoa/Rpia/Slc4a1/Snca/Tkt/Tpi1/Vcp,10
BP,GO:2001236,regulation of extrinsic apoptotic signaling pathway,7/85,165/23355,2.40E-06,9.66E-05,6.73E-05,Fga/Fgb/Fgg/Gpx1/Pf4/Prdx2/Thbs1,7
BP,GO:0016485,protein processing,8/85,238/23355,2.53E-06,9.99E-05,6.95E-05,Capn1/F9/Fga/Fgb/Fgg/Hp/Srgn/Thbs1,8
BP,GO:0051251,positive regulation of lymphocyte activation,10/85,417/23355,2.81E-06,0.000108552,7.56E-05,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Pnp/Rhoa/Slc4a1/Spta1,10
BP,GO:0045454,cell redox homeostasis,5/85,66/23355,4.26E-06,0.000161453,0.000112399,Gpx1/Prdx1/Prdx2/Prdx6/Txnrd2,5
BP,GO:0046034,ATP metabolic process,8/85,256/23355,4.34E-06,0.000161661,0.000112544,Bpgm/Eno1/Ldha/Rhoa/Slc4a1/Snca/Tpi1/Vcp,8
BP,GO:1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,4/85,31/23355,4.77E-06,0.000174385,0.000121402,Fga/Fgb/Fgg/Gpx1,4
BP,GO:0030837,negative regulation of actin filament polymerization,5/85,68/23355,4.93E-06,0.000177219,0.000123374,Capn1/Cfl1/Pfn1/Spta1/Sptb,5
BP,GO:0022409,positive regulation of cell-cell adhesion,8/85,267/23355,5.91E-06,0.000208578,0.000145206,Capn1/Fga/Fgb/Fgg/Pnp/Rhoa/Slc4a1/Spta1,8
BP,GO:0031589,cell-substrate adhesion,9/85,358/23355,6.24E-06,0.000216516,0.000150732,Cfl1/Enpp2/Fga/Fgb/Fgg/Gp5/Rhoa/Thbs1/Vwf,9
BP,GO:0061045,negative regulation of wound healing,5/85,72/23355,6.55E-06,0.000223213,0.000155394,Fga/Fgb/Fgg/Gp5/Thbs1,5
BP,GO:1990266,neutrophil migration,6/85,126/23355,6.75E-06,0.000226314,0.000157553,Ccl8/Lbp/Pf4/Ppbp/Ppia/Thbs4,6
BP,GO:0034599,cellular response to oxidative stress,8/85,274/23355,7.14E-06,0.0002355,0.000163948,Capn1/Cfl1/Gpx1/Ppia/Prdx1/Prdx2/Snca/Thbs1,8
BP,GO:0061041,regulation of wound healing,6/85,129/23355,7.73E-06,0.000250545,0.000174422,Fga/Fgb/Fgg/Gp5/Prdx2/Thbs1,6
BP,GO:1990748,cellular detoxification,4/85,35/23355,7.85E-06,0.000250545,0.000174422,Esd/Prdx1/Prdx2/Prdx6,4
BP,GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,5/85,78/23355,9.71E-06,0.000304612,0.000212062,Fga/Fgb/Fgg/Gpx1/Thbs1,5
BP,GO:1901068,guanosine-containing compound metabolic process,4/85,37/23355,9.85E-06,0.000304612,0.000212062,Gda/Nme1/Pnp/Rhoa,4
BP,GO:2000377,regulation of reactive oxygen species metabolic process,7/85,207/23355,1.07E-05,0.000325251,0.00022643,Eef1a1/Eif5a/Hp/Prdx2/Rhoa/Snca/Thbs1,7
BP,GO:0009116,nucleoside metabolic process,5/85,81/23355,1.17E-05,0.000350832,0.000244239,Atic/Gda/Nme1/Pnp/Rhoa,5
BP,GO:0072376,protein activation cascade,3/85,13/23355,1.30E-05,0.00038328,0.000266829,Fga/Fgb/Fgg,3
BP,GO:0006778,porphyrin-containing compound metabolic process,4/85,40/23355,1.35E-05,0.000393785,0.000274141,Ank1/Blvrb/Spta1/Sptb,4
BP,GO:0051604,protein maturation,8/85,303/23355,1.48E-05,0.000425717,0.000296372,Capn1/F9/Fga/Fgb/Fgg/Hp/Srgn/Thbs1,8
BP,GO:0031333,negative regulation of protein-containing complex assembly,6/85,147/23355,1.63E-05,0.000447216,0.000311339,Capn1/Cfl1/Pfn1/Snca/Spta1/Sptb,6
BP,GO:0050871,positive regulation of B cell activation,7/85,221/23355,1.63E-05,0.000447216,0.000311339,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Pnp,7
BP,GO:0034116,positive regulation of heterotypic cell-cell adhesion,3/85,14/23355,1.65E-05,0.000447216,0.000311339,Fga/Fgb/Fgg,3
BP,GO:0097237,cellular response to toxic substance,4/85,42/23355,1.65E-05,0.000447216,0.000311339,Esd/Prdx1/Prdx2/Prdx6,4
BP,GO:0051702,biological process involved in interaction with symbiont,5/85,91/23355,2.06E-05,0.000545606,0.000379835,Cfl1/Gpx1/Ltf/Pf4/Stom,5
BP,GO:1903035,negative regulation of response to wounding,5/85,91/23355,2.06E-05,0.000545606,0.000379835,Fga/Fgb/Fgg/Gp5/Thbs1,5
BP,GO:0097191,extrinsic apoptotic signaling pathway,7/85,233/23355,2.29E-05,0.000598431,0.000416611,Fga/Fgb/Fgg/Gpx1/Pf4/Prdx2/Thbs1,7
BP,GO:2001234,negative regulation of apoptotic signaling pathway,7/85,234/23355,2.36E-05,0.000602463,0.000419418,Fga/Fgb/Fgg/Gpx1/Pf4/Ppia/Prdx2,7
BP,GO:0046390,ribose phosphate biosynthetic process,6/85,157/23355,2.37E-05,0.000602463,0.000419418,Atic/Nme1/Pnp/Snca/Tkt/Vcp,6
BP,GO:0098885,modification of postsynaptic actin cytoskeleton,3/85,16/23355,2.52E-05,0.000631073,0.000439334,Cfl1/Pfn1/Rhoa,3
BP,GO:0006910,"phagocytosis, recognition",6/85,159/23355,2.54E-05,0.000631073,0.000439334,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0022407,regulation of cell-cell adhesion,9/85,432/23355,2.77E-05,0.000665679,0.000463427,Capn1/Fga/Fgb/Fgg/Pnp/Prdx2/Rhoa/Slc4a1/Spta1,9
BP,GO:0062197,cellular response to chemical stress,8/85,331/23355,2.79E-05,0.000665679,0.000463427,Capn1/Cfl1/Gpx1/Ppia/Prdx1/Prdx2/Snca/Thbs1,8
BP,GO:0033013,tetrapyrrole metabolic process,4/85,48/23355,2.81E-05,0.000665679,0.000463427,Ank1/Blvrb/Spta1/Sptb,4
BP,GO:0045907,positive regulation of vasoconstriction,4/85,48/23355,2.81E-05,0.000665679,0.000463427,Fga/Fgb/Fgg/Rhoa,4
BP,GO:0010310,regulation of hydrogen peroxide metabolic process,3/85,17/23355,3.05E-05,0.000713011,0.000496377,Hp/Prdx2/Snca,3
BP,GO:0006958,"complement activation, classical pathway",6/85,166/23355,3.24E-05,0.000731869,0.000509506,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0019730,antimicrobial humoral response,6/85,166/23355,3.24E-05,0.000731869,0.000509506,Fga/Fgb/Krt6a/Ltf/Pf4/Ppbp,6
BP,GO:0043254,regulation of protein-containing complex assembly,9/85,441/23355,3.26E-05,0.000731869,0.000509506,Capn1/Cfl1/Gda/Pfn1/Rhoa/Snca/Spta1/Sptb/Vcp,9
BP,GO:0070527,platelet aggregation,4/85,50/23355,3.31E-05,0.000731869,0.000509506,Fga/Fgb/Fgg/Ppia,4
BP,GO:0098754,detoxification,4/85,50/23355,3.31E-05,0.000731869,0.000509506,Esd/Prdx1/Prdx2/Prdx6,4
BP,GO:1903034,regulation of response to wounding,6/85,170/23355,3.70E-05,0.000809064,0.000563247,Fga/Fgb/Fgg/Gp5/Prdx2/Thbs1,6
BP,GO:1901657,glycosyl compound metabolic process,5/85,104/23355,3.93E-05,0.00082779,0.000576284,Atic/Gda/Nme1/Pnp/Rhoa,5
BP,GO:0030833,regulation of actin filament polymerization,6/85,172/23355,3.95E-05,0.00082779,0.000576284,Capn1/Cfl1/Pfn1/Rhoa/Spta1/Sptb,6
BP,GO:0051494,negative regulation of cytoskeleton organization,6/85,172/23355,3.95E-05,0.00082779,0.000576284,Capn1/Cfl1/Pfn1/Snca/Spta1/Sptb,6
BP,GO:1902904,negative regulation of supramolecular fiber organization,6/85,172/23355,3.95E-05,0.00082779,0.000576284,Capn1/Cfl1/Pfn1/Snca/Spta1/Sptb,6
BP,GO:0098869,cellular oxidant detoxification,3/85,19/23355,4.32E-05,0.00089609,0.000623832,Prdx1/Prdx2/Prdx6,3
BP,GO:0006165,nucleoside diphosphate phosphorylation,5/85,107/23355,4.50E-05,0.000924191,0.000643395,Bpgm/Eno1/Nme1/Slc4a1/Tpi1,5
BP,GO:2000351,regulation of endothelial cell apoptotic process,4/85,55/23355,4.84E-05,0.000982561,0.000684031,Fga/Fgb/Fgg/Thbs1,4
BP,GO:0046939,nucleotide phosphorylation,5/85,110/23355,5.14E-05,0.001015505,0.000706966,Bpgm/Eno1/Nme1/Slc4a1/Tpi1,5
BP,GO:0006909,phagocytosis,8/85,361/23355,5.15E-05,0.001015505,0.000706966,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Lbp/Thbs1,8
BP,GO:0046128,purine ribonucleoside metabolic process,4/85,56/23355,5.19E-05,0.001015505,0.000706966,Gda/Nme1/Pnp/Rhoa,4
BP,GO:0002455,humoral immune response mediated by circulating immunoglobulin,6/85,181/23355,5.25E-05,0.001015505,0.000706966,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0050853,B cell receptor signaling pathway,6/85,181/23355,5.25E-05,0.001015505,0.000706966,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0072577,endothelial cell apoptotic process,4/85,58/23355,5.97E-05,0.001142927,0.000795672,Fga/Fgb/Fgg/Thbs1,4
BP,GO:0050864,regulation of B cell activation,7/85,272/23355,6.12E-05,0.001161364,0.000808508,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Pnp,7
BP,GO:0006956,complement activation,6/85,187/23355,6.29E-05,0.001182924,0.000823517,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0009636,response to toxic substance,5/85,115/23355,6.36E-05,0.00118346,0.00082389,Esd/Gpx1/Prdx1/Prdx2/Prdx6,5
BP,GO:0030041,actin filament polymerization,6/85,188/23355,6.48E-05,0.001196039,0.000832648,Capn1/Cfl1/Pfn1/Rhoa/Spta1/Sptb,6
BP,GO:0000305,response to oxygen radical,3/85,22/23355,6.82E-05,0.001234213,0.000859223,Prdx1/Prdx2/Txnrd2,3
BP,GO:0042278,purine nucleoside metabolic process,4/85,60/23355,6.82E-05,0.001234213,0.000859223,Gda/Nme1/Pnp/Rhoa,4
BP,GO:0008064,regulation of actin polymerization or depolymerization,6/85,190/23355,6.87E-05,0.001234213,0.000859223,Capn1/Cfl1/Pfn1/Rhoa/Spta1/Sptb,6
BP,GO:0032102,negative regulation of response to external stimulus,8/85,380/23355,7.37E-05,0.001300737,0.000905535,Fga/Fgb/Fgg/Gp5/Gpx1/Ltf/Prdx2/Thbs1,8
BP,GO:1902903,regulation of supramolecular fiber organization,8/85,380/23355,7.37E-05,0.001300737,0.000905535,Capn1/Cfl1/Gda/Pfn1/Rhoa/Snca/Spta1/Sptb,8
BP,GO:0030832,regulation of actin filament length,6/85,193/23355,7.50E-05,0.001310723,0.000912488,Capn1/Cfl1/Pfn1/Rhoa/Spta1/Sptb,6
BP,GO:0009119,ribonucleoside metabolic process,4/85,62/23355,7.76E-05,0.001345289,0.000936551,Gda/Nme1/Pnp/Rhoa,4
BP,GO:0006090,pyruvate metabolic process,5/85,121/23355,8.09E-05,0.001379256,0.000960198,Bpgm/Eno1/Ldha/Slc4a1/Tpi1,5
BP,GO:0042542,response to hydrogen peroxide,5/85,121/23355,8.09E-05,0.001379256,0.000960198,Capn1/Cfl1/Gpx1/Hp/Slc4a1,5
BP,GO:0006081,cellular aldehyde metabolic process,4/85,63/23355,8.26E-05,0.001396414,0.000972143,Esd/Glo1/Tkt/Tpi1,4
BP,GO:0044403,biological process involved in symbiotic interaction,8/85,390/23355,8.83E-05,0.001479978,0.001030318,Cfl1/Gpx1/Ltf/Pf4/Pfn1/Ppia/Stom/Vcp,8
BP,GO:2001233,regulation of apoptotic signaling pathway,8/85,391/23355,8.99E-05,0.001494016,0.001040091,Fga/Fgb/Fgg/Gpx1/Pf4/Ppia/Prdx2/Thbs1,8
BP,GO:0034114,regulation of heterotypic cell-cell adhesion,3/85,25/23355,0.000100986,0.001663582,0.001158137,Fga/Fgb/Fgg,3
BP,GO:0009132,nucleoside diphosphate metabolic process,5/85,127/23355,0.000101751,0.001663582,0.001158137,Bpgm/Eno1/Nme1/Slc4a1/Tpi1,5
BP,GO:0051592,response to calcium ion,5/85,129/23355,0.000109532,0.001776364,0.001236653,Fga/Fgb/Fgg/Gdi1/Thbs1,5
BP,GO:0046039,GTP metabolic process,3/85,26/23355,0.000113859,0.00181722,0.001265096,Nme1/Pnp/Rhoa,3
BP,GO:0099010,modification of postsynaptic structure,3/85,26/23355,0.000113859,0.00181722,0.001265096,Cfl1/Pfn1/Rhoa,3
BP,GO:0051354,negative regulation of oxidoreductase activity,3/85,27/23355,0.000127755,0.002022951,0.00140832,Hp/Slc4a1/Snca,3
BP,GO:1990868,response to chemokine,4/85,71/23355,0.000131839,0.002055265,0.001430816,Ccl8/Pf4/Ppbp/Rhoa,4
BP,GO:1990869,cellular response to chemokine,4/85,71/23355,0.000131839,0.002055265,0.001430816,Ccl8/Pf4/Ppbp/Rhoa,4
BP,GO:0008154,actin polymerization or depolymerization,6/85,215/23355,0.00013552,0.002096387,0.001459444,Capn1/Cfl1/Pfn1/Rhoa/Spta1/Sptb,6
BP,GO:0006779,porphyrin-containing compound biosynthetic process,3/85,28/23355,0.00014271,0.002174162,0.001513589,Ank1/Spta1/Sptb,3
BP,GO:0033014,tetrapyrrole biosynthetic process,3/85,28/23355,0.00014271,0.002174162,0.001513589,Ank1/Spta1/Sptb,3
BP,GO:0052547,regulation of peptidase activity,8/85,422/23355,0.000151932,0.002297254,0.001599282,Cst3/Gpx1/Ltf/Pebp1/Rhoa/Snca/Thbs1/Vcp,8
BP,GO:0003018,vascular process in circulatory system,6/85,221/23355,0.000157412,0.00236236,0.001644607,Capn1/Fga/Fgb/Fgg/Gpx1/Rhoa,6
BP,GO:0009152,purine ribonucleotide biosynthetic process,5/85,141/23355,0.00016627,0.002476803,0.001724279,Atic/Nme1/Pnp/Snca/Vcp,5
BP,GO:0016052,carbohydrate catabolic process,5/85,142/23355,0.000171849,0.002541094,0.001769036,Bpgm/Eno1/Ldha/Slc4a1/Tpi1,5
BP,GO:0034109,homotypic cell-cell adhesion,4/85,77/23355,0.000180605,0.002651067,0.001845596,Fga/Fgb/Fgg/Ppia,4
BP,GO:0002449,lymphocyte mediated immunity,8/85,435/23355,0.000186802,0.002722168,0.001895095,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Pnp/Prdx1,8
BP,GO:0044788,modulation by host of viral process,3/85,31/23355,0.000194275,0.002810696,0.001956725,Cfl1/Ltf/Stom,3
BP,GO:0009205,purine ribonucleoside triphosphate metabolic process,4/85,79/23355,0.000199416,0.002864461,0.001994155,Nme1/Pnp/Rhoa/Vcp,4
BP,GO:0034614,cellular response to reactive oxygen species,5/85,147/23355,0.000201924,0.00287993,0.002004924,Capn1/Cfl1/Prdx1/Prdx2/Thbs1,5
BP,GO:2000116,regulation of cysteine-type endopeptidase activity,6/85,232/23355,0.00020476,0.002899803,0.002018759,Gpx1/Ltf/Rhoa/Snca/Thbs1/Vcp,6
BP,GO:0019229,regulation of vasoconstriction,4/85,80/23355,0.000209332,0.002943826,0.002049406,Fga/Fgb/Fgg/Rhoa,4
BP,GO:2000352,negative regulation of endothelial cell apoptotic process,3/85,32/23355,0.00021381,0.002985915,0.002078708,Fga/Fgb/Fgg,3
BP,GO:0009260,ribonucleotide biosynthetic process,5/85,150/23355,0.000221801,0.003076146,0.002141524,Atic/Nme1/Pnp/Snca/Vcp,5
BP,GO:0046434,organophosphate catabolic process,5/85,151/23355,0.000228746,0.003149532,0.002192613,Enpp2/Gda/Pnp/Prdx6/Vcp,5
BP,GO:0009199,ribonucleoside triphosphate metabolic process,4/85,82/23355,0.000230224,0.003149532,0.002192613,Nme1/Pnp/Rhoa/Vcp,4
BP,GO:0008360,regulation of cell shape,5/85,154/23355,0.00025058,0.003404843,0.002370353,Arhgdia/Cfl1/Epb41/Rhoa/Spta1,5
BP,GO:0099563,modification of synaptic structure,3/85,34/23355,0.0002566,0.003463242,0.002411009,Cfl1/Pfn1/Rhoa,3
BP,GO:0010466,negative regulation of peptidase activity,6/85,244/23355,0.000268548,0.003600331,0.002506446,Cst3/Gpx1/Ltf/Pebp1/Snca/Thbs1,6
BP,GO:2000117,negative regulation of cysteine-type endopeptidase activity,4/85,87/23355,0.000288973,0.00384851,0.002679221,Gpx1/Ltf/Snca/Thbs1,4
BP,GO:0006164,purine nucleotide biosynthetic process,5/85,160/23355,0.00029897,0.003955447,0.002753668,Atic/Nme1/Pnp/Snca/Vcp,5
BP,GO:0009144,purine nucleoside triphosphate metabolic process,4/85,88/23355,0.0003019,0.003968105,0.00276248,Nme1/Pnp/Rhoa/Vcp,4
BP,GO:0007159,leukocyte cell-cell adhesion,7/85,353/23355,0.000305175,0.003985107,0.002774316,Capn1/Pnp/Prdx2/Rhoa/Slc4a1/Spta1/Thbs1,7
BP,GO:0035296,regulation of tube diameter,5/85,162/23355,0.000316577,0.004081004,0.002841077,Fga/Fgb/Fgg/Gpx1/Rhoa,5
BP,GO:0097746,blood vessel diameter maintenance,5/85,162/23355,0.000316577,0.004081004,0.002841077,Fga/Fgb/Fgg/Gpx1/Rhoa,5
BP,GO:0035150,regulation of tube size,5/85,163/23355,0.00032567,0.004171483,0.002904066,Fga/Fgb/Fgg/Gpx1/Rhoa,5
BP,GO:0009167,purine ribonucleoside monophosphate metabolic process,3/85,37/23355,0.000330572,0.004207474,0.002929122,Atic/Gda/Pnp,3
BP,GO:0010639,negative regulation of organelle organization,7/85,359/23355,0.00033778,0.004272169,0.00297416,Capn1/Cfl1/Gpx1/Pfn1/Snca/Spta1/Sptb,7
BP,GO:0072522,purine-containing compound biosynthetic process,5/85,165/23355,0.000344449,0.004329294,0.003013929,Atic/Nme1/Pnp/Snca/Vcp,5
BP,GO:0009126,purine nucleoside monophosphate metabolic process,3/85,38/23355,0.000357966,0.004471246,0.003112752,Atic/Gda/Pnp,3
BP,GO:0032956,regulation of actin cytoskeleton organization,7/85,364/23355,0.000367038,0.00455625,0.00317193,Arhgdia/Capn1/Cfl1/Pfn1/Rhoa/Spta1/Sptb,7
BP,GO:0006096,glycolytic process,4/85,93/23355,0.000372827,0.004599723,0.003202194,Bpgm/Eno1/Slc4a1/Tpi1,4
BP,GO:0006757,ATP generation from ADP,4/85,94/23355,0.000388324,0.004732852,0.003294874,Bpgm/Eno1/Slc4a1/Tpi1,4
BP,GO:0034404,nucleobase-containing small molecule biosynthetic process,4/85,94/23355,0.000388324,0.004732852,0.003294874,Gda/Nme1/Pnp/Vcp,4
BP,GO:0032496,response to lipopolysaccharide,7/85,372/23355,0.00041805,0.005064453,0.003525725,Lbp/Ltf/Pf4/Ppbp/Prdx2/Rhoa/Snca,7
BP,GO:1904035,regulation of epithelial cell apoptotic process,4/85,96/23355,0.000420693,0.005065948,0.003526766,Fga/Fgb/Fgg/Thbs1,4
BP,GO:0016064,immunoglobulin mediated immune response,6/85,267/23355,0.000433791,0.005192582,0.003614925,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0051693,actin filament capping,3/85,41/23355,0.000448792,0.005340358,0.003717803,Cfl1/Spta1/Sptb,3
BP,GO:0019724,B cell mediated immunity,6/85,271/23355,0.000469231,0.005550731,0.003864258,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0045921,positive regulation of exocytosis,4/85,100/23355,0.000491138,0.005775893,0.00402101,Fga/Fgb/Fgg/Snca,4
BP,GO:0071902,positive regulation of protein serine/threonine kinase activity,6/85,274/23355,0.000497264,0.005813938,0.004047495,Ltf/Ppia/Prdx2/Rhoa/Snca/Thbs1,6
BP,GO:0110053,regulation of actin filament organization,6/85,276/23355,0.000516666,0.006005865,0.004181109,Capn1/Cfl1/Pfn1/Rhoa/Spta1/Sptb,6
BP,GO:0046031,ADP metabolic process,4/85,102/23355,0.000529338,0.006117807,0.00425904,Bpgm/Eno1/Slc4a1/Tpi1,4
BP,GO:0048821,erythrocyte development,3/85,44/23355,0.000553211,0.006357181,0.004425685,Ank1/Bpgm/Slc4a1,3
BP,GO:0010038,response to metal ion,6/85,281/23355,0.000567757,0.006472746,0.004506139,Fga/Fgb/Fgg/Gdi1/Snca/Thbs1,6
BP,GO:0006183,GTP biosynthetic process,2/85,10/23355,0.00057801,0.006472746,0.004506139,Nme1/Pnp,2
BP,GO:0009172,purine deoxyribonucleoside monophosphate catabolic process,2/85,10/23355,0.00057801,0.006472746,0.004506139,Gda/Pnp,2
BP,GO:1901069,guanosine-containing compound catabolic process,2/85,10/23355,0.00057801,0.006472746,0.004506139,Gda/Pnp,2
BP,GO:0002237,response to molecule of bacterial origin,7/85,393/23355,0.000579361,0.006472746,0.004506139,Lbp/Ltf/Pf4/Ppbp/Prdx2/Rhoa/Snca,7
BP,GO:0042310,vasoconstriction,4/85,105/23355,0.000590536,0.006561143,0.004567678,Fga/Fgb/Fgg/Rhoa,4
BP,GO:0009135,purine nucleoside diphosphate metabolic process,4/85,106/23355,0.000612005,0.00672537,0.004682008,Bpgm/Eno1/Slc4a1/Tpi1,4
BP,GO:0009179,purine ribonucleoside diphosphate metabolic process,4/85,106/23355,0.000612005,0.00672537,0.004682008,Bpgm/Eno1/Slc4a1/Tpi1,4
BP,GO:0008037,cell recognition,6/85,287/23355,0.000634162,0.006930979,0.004825147,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0071222,cellular response to lipopolysaccharide,6/85,288/23355,0.000645792,0.007019937,0.004887077,Lbp/Ltf/Pf4/Ppbp/Prdx2/Rhoa,6
BP,GO:0009141,nucleoside triphosphate metabolic process,4/85,108/23355,0.000656598,0.007099023,0.004942134,Nme1/Pnp/Rhoa/Vcp,4
BP,GO:0030835,negative regulation of actin filament depolymerization,3/85,47/23355,0.000672006,0.007226764,0.005031064,Cfl1/Spta1/Sptb,3
BP,GO:0002679,respiratory burst involved in defense response,2/85,11/23355,0.000704786,0.007438058,0.005178161,Lbp/Prdx2,2
BP,GO:0009170,purine deoxyribonucleoside monophosphate metabolic process,2/85,11/23355,0.000704786,0.007438058,0.005178161,Gda/Pnp,2
BP,GO:0034145,positive regulation of toll-like receptor 4 signaling pathway,2/85,11/23355,0.000704786,0.007438058,0.005178161,Lbp/Ltf,2
BP,GO:0007162,negative regulation of cell adhesion,6/85,293/23355,0.000706449,0.007438058,0.005178161,Cfl1/Enpp2/Fgg/Prdx2/Rhoa/Thbs1,6
BP,GO:0009185,ribonucleoside diphosphate metabolic process,4/85,111/23355,0.000727737,0.007622287,0.005306415,Bpgm/Eno1/Slc4a1/Tpi1,4
BP,GO:0032970,regulation of actin filament-based process,7/85,411/23355,0.000754002,0.007856464,0.005469443,Arhgdia/Capn1/Cfl1/Pfn1/Rhoa/Spta1/Sptb,7
BP,GO:0009161,ribonucleoside monophosphate metabolic process,3/85,49/23355,0.000759564,0.007873629,0.005481392,Atic/Gda/Pnp,3
BP,GO:0071219,cellular response to molecule of bacterial origin,6/85,298/23355,0.000771432,0.007955644,0.005538489,Lbp/Ltf/Pf4/Ppbp/Prdx2/Rhoa,6
BP,GO:0048771,tissue remodeling,5/85,198/23355,0.000788644,0.008091645,0.005633169,Car2/Capn1/Cela1/Flt4/Thbs4,5
BP,GO:0050851,antigen receptor-mediated signaling pathway,6/85,301/23355,0.000812585,0.008294968,0.005774716,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0032535,regulation of cellular component size,7/85,417/23355,0.00082068,0.008335287,0.005802786,Capn1/Cfl1/Gdi1/Pfn1/Rhoa/Spta1/Sptb,7
BP,GO:0031663,lipopolysaccharide-mediated signaling pathway,3/85,51/23355,0.000854064,0.008585892,0.005977249,Lbp/Ltf/Prdx2,3
BP,GO:0010631,epithelial cell migration,6/85,304/23355,0.000855415,0.008585892,0.005977249,Enpp2/Flt4/Gpx1/Pfn1/Rhoa/Thbs1,6
BP,GO:0019079,viral genome replication,4/85,116/23355,0.000858162,0.008585892,0.005977249,Ltf/Ppia/Stom/Vcp,4
BP,GO:0030099,myeloid cell differentiation,7/85,422/23355,0.000879739,0.008723436,0.006073004,Ank1/Bpgm/Car2/Glo1/Nme1/Pf4/Slc4a1,7
BP,GO:0009165,nucleotide biosynthetic process,5/85,203/23355,0.000881936,0.008723436,0.006073004,Atic/Nme1/Pnp/Snca/Vcp,5
BP,GO:0090132,epithelium migration,6/85,306/23355,0.000884923,0.008723436,0.006073004,Enpp2/Flt4/Gpx1/Pfn1/Rhoa/Thbs1,6
BP,GO:0042113,B cell activation,7/85,423/23355,0.000891944,0.00874975,0.006091323,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Pnp,7
BP,GO:1902105,regulation of leukocyte differentiation,6/85,307/23355,0.000899969,0.00878562,0.006116294,Car2/Nme1/Pf4/Pnp/Prdx2/Rhoa,6
BP,GO:0090130,tissue migration,6/85,308/23355,0.000915211,0.008891256,0.006189835,Enpp2/Flt4/Gpx1/Pfn1/Rhoa/Thbs1,6
BP,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,5/85,207/23355,0.000962304,0.009303809,0.006477043,Gpx1/Rhoa/Snca/Thbs1/Vcp,5
BP,GO:1901293,nucleoside phosphate biosynthetic process,5/85,208/23355,0.00098322,0.00936823,0.00652189,Atic/Nme1/Pnp/Snca/Vcp,5
BP,GO:0006098,pentose-phosphate shunt,2/85,13/23355,0.000994796,0.00936823,0.00652189,Rpia/Tkt,2
BP,GO:0032026,response to magnesium ion,2/85,13/23355,0.000994796,0.00936823,0.00652189,Snca/Thbs1,2
BP,GO:0046037,GMP metabolic process,2/85,13/23355,0.000994796,0.00936823,0.00652189,Gda/Pnp,2
BP,GO:1901070,guanosine-containing compound biosynthetic process,2/85,13/23355,0.000994796,0.00936823,0.00652189,Nme1/Pnp,2
BP,GO:1904019,epithelial cell apoptotic process,4/85,121/23355,0.00100427,0.00936823,0.00652189,Fga/Fgb/Fgg/Thbs1,4
BP,GO:0034113,heterotypic cell-cell adhesion,3/85,54/23355,0.00100929,0.00936823,0.00652189,Fga/Fgb/Fgg,3
BP,GO:1904036,negative regulation of epithelial cell apoptotic process,3/85,54/23355,0.00100929,0.00936823,0.00652189,Fga/Fgb/Fgg,3
BP,GO:1903037,regulation of leukocyte cell-cell adhesion,6/85,314/23355,0.001010893,0.00936823,0.00652189,Capn1/Pnp/Prdx2/Rhoa/Slc4a1/Spta1,6
BP,GO:0090407,organophosphate biosynthetic process,7/85,434/23355,0.001035241,0.009549857,0.006648334,Atic/Nme1/Pnp/Snca/Tkt/Tpi1/Vcp,7
BP,GO:0044282,small molecule catabolic process,6/85,316/23355,0.00104444,0.009590724,0.006676785,Esd/Gda/Glo1/Ldha/Pnp/Tpi1,6
BP,GO:0001667,ameboidal-type cell migration,7/85,439/23355,0.001106095,0.010110714,0.007038787,Cfl1/Enpp2/Flt4/Gpx1/Pfn1/Rhoa/Thbs1,7
BP,GO:0030834,regulation of actin filament depolymerization,3/85,56/23355,0.001122055,0.010123664,0.007047802,Cfl1/Spta1/Sptb,3
BP,GO:0071622,regulation of granulocyte chemotaxis,3/85,56/23355,0.001122055,0.010123664,0.007047802,Lbp/Thbs1/Thbs4,3
BP,GO:0032984,protein-containing complex disassembly,5/85,215/23355,0.001139242,0.010123664,0.007047802,Cfl1/Eif5a/Spta1/Sptb/Vcp,5
BP,GO:0016032,viral process,6/85,322/23355,0.00115024,0.010123664,0.007047802,Cfl1/Ltf/Pfn1/Ppia/Stom/Vcp,6
BP,GO:0006152,purine nucleoside catabolic process,2/85,14/23355,0.001157853,0.010123664,0.007047802,Gda/Pnp,2
BP,GO:0006740,NADPH regeneration,2/85,14/23355,0.001157853,0.010123664,0.007047802,Rpia/Tkt,2
BP,GO:0009169,purine ribonucleoside monophosphate catabolic process,2/85,14/23355,0.001157853,0.010123664,0.007047802,Gda/Pnp,2
BP,GO:0045792,negative regulation of cell size,2/85,14/23355,0.001157853,0.010123664,0.007047802,Cfl1/Rhoa,2
BP,GO:0046130,purine ribonucleoside catabolic process,2/85,14/23355,0.001157853,0.010123664,0.007047802,Gda/Pnp,2
BP,GO:0046185,aldehyde catabolic process,2/85,14/23355,0.001157853,0.010123664,0.007047802,Esd/Glo1,2
BP,GO:0071216,cellular response to biotic stimulus,6/85,323/23355,0.001168644,0.010173782,0.007082692,Lbp/Ltf/Pf4/Ppbp/Prdx2/Rhoa,6
BP,GO:0043030,regulation of macrophage activation,3/85,57/23355,0.001181296,0.010239594,0.007128509,Lbp/Snca/Thbs1,3
BP,GO:0002685,regulation of leukocyte migration,5/85,217/23355,0.001187011,0.010244978,0.007132257,Capn1/Lbp/Rhoa/Thbs1/Thbs4,5
BP,GO:0070374,positive regulation of ERK1 and ERK2 cascade,5/85,218/23355,0.001211445,0.010411178,0.007247961,Ccl8/Fga/Fgb/Fgg/Flt4,5
BP,GO:0009123,nucleoside monophosphate metabolic process,3/85,58/23355,0.001242475,0.010632415,0.007401979,Atic/Gda/Pnp,3
BP,GO:0022604,regulation of cell morphogenesis,6/85,328/23355,0.001264083,0.010757435,0.007489015,Arhgdia/Cfl1/Enpp2/Epb41/Rhoa/Spta1,6
BP,GO:0043244,regulation of protein-containing complex disassembly,4/85,129/23355,0.001273133,0.010757435,0.007489015,Cfl1/Eif5a/Spta1/Sptb,4
BP,GO:0061844,antimicrobial humoral immune response mediated by antimicrobial peptide,4/85,129/23355,0.001273133,0.010757435,0.007489015,Krt6a/Ltf/Pf4/Ppbp,4
BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7/85,452/23355,0.001308278,0.011008146,0.007663553,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1/Pnp,7
BP,GO:0009128,purine nucleoside monophosphate catabolic process,2/85,15/23355,0.001332829,0.011121656,0.007742575,Gda/Pnp,2
BP,GO:0009155,purine deoxyribonucleotide catabolic process,2/85,15/23355,0.001332829,0.011121656,0.007742575,Gda/Pnp,2
BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,5/85,223/23355,0.001339242,0.011128989,0.00774768,Capn1/Pnp/Rhoa/Slc4a1/Spta1,5
BP,GO:0030042,actin filament depolymerization,3/85,60/23355,0.001370743,0.011297394,0.007864919,Cfl1/Spta1/Sptb,3
BP,GO:0051851,modulation by host of symbiont process,3/85,60/23355,0.001370743,0.011297394,0.007864919,Cfl1/Ltf/Stom,3
BP,GO:0002429,immune response-activating cell surface receptor signaling pathway,6/85,334/23355,0.00138637,0.011379553,0.007922115,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0002757,immune response-activating signal transduction,6/85,335/23355,0.001407601,0.011506849,0.008010735,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0070098,chemokine-mediated signaling pathway,3/85,61/23355,0.001437878,0.011706774,0.008149918,Ccl8/Pf4/Ppbp,3
BP,GO:0010812,negative regulation of cell-substrate adhesion,3/85,62/23355,0.001507045,0.012220433,0.008507512,Enpp2/Rhoa/Thbs1,3
BP,GO:0019430,removal of superoxide radicals,2/85,16/23355,0.001519636,0.012223956,0.008509964,Prdx1/Prdx2,2
BP,GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,2/85,16/23355,0.001519636,0.012223956,0.008509964,Rhoa/Thbs1,2
BP,GO:0045861,negative regulation of proteolysis,6/85,342/23355,0.001563257,0.012524739,0.008719361,Cst3/Gpx1/Ltf/Pebp1/Snca/Thbs1,6
BP,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,3/85,64/23355,0.001651562,0.01317973,0.009175347,Nme1/Pnp/Vcp,3
BP,GO:0002768,immune response-regulating cell surface receptor signaling pathway,6/85,347/23355,0.001682237,0.013289532,0.009251787,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0048732,gland development,7/85,473/23355,0.001694965,0.013289532,0.009251787,Capn1/Cela1/Gpx1/Hp/Nme1/Prdx2/Vwf,7
BP,GO:0052548,regulation of endopeptidase activity,6/85,348/23355,0.001706838,0.013289532,0.009251787,Gpx1/Ltf/Rhoa/Snca/Thbs1/Vcp,6
BP,GO:0043901,negative regulation of multi-organism process,2/85,17/23355,0.001718189,0.013289532,0.009251787,Ltf/Prdx2,2
BP,GO:0044794,positive regulation by host of viral process,2/85,17/23355,0.001718189,0.013289532,0.009251787,Cfl1/Stom,2
BP,GO:0046040,IMP metabolic process,2/85,17/23355,0.001718189,0.013289532,0.009251787,Atic/Pnp,2
BP,GO:0098760,response to interleukin-7,2/85,17/23355,0.001718189,0.013289532,0.009251787,Atic/Eno1,2
BP,GO:0098761,cellular response to interleukin-7,2/85,17/23355,0.001718189,0.013289532,0.009251787,Atic/Eno1,2
BP,GO:0009145,purine nucleoside triphosphate biosynthetic process,3/85,65/23355,0.001726957,0.013306173,0.009263372,Nme1/Pnp/Vcp,3
BP,GO:0002764,immune response-regulating signaling pathway,6/85,350/23355,0.00175686,0.013484909,0.009387803,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0009166,nucleotide catabolic process,3/85,66/23355,0.001804472,0.01372594,0.009555602,Gda/Pnp/Vcp,3
BP,GO:0048524,positive regulation of viral process,3/85,66/23355,0.001804472,0.01372594,0.009555602,Pfn1/Ppia/Stom,3
BP,GO:1901136,carbohydrate derivative catabolic process,4/85,142/23355,0.001811499,0.01372594,0.009555602,Cela1/Cst3/Gda/Pnp,4
BP,GO:0031334,positive regulation of protein-containing complex assembly,5/85,239/23355,0.001815564,0.01372594,0.009555602,Gda/Pfn1/Rhoa/Snca/Vcp,5
BP,GO:0010632,regulation of epithelial cell migration,5/85,240/23355,0.001848964,0.013926096,0.009694945,Enpp2/Flt4/Pfn1/Rhoa/Thbs1,5
BP,GO:0009201,ribonucleoside triphosphate biosynthetic process,3/85,67/23355,0.001884127,0.014105383,0.00981976,Nme1/Pnp/Vcp,3
BP,GO:0048872,homeostasis of number of cells,6/85,355/23355,0.001886797,0.014105383,0.00981976,Ank1/Bpgm/Prdx1/Prdx2/Slc4a1/Spta1,6
BP,GO:0046184,aldehyde biosynthetic process,2/85,18/23355,0.001928401,0.014205181,0.009889236,Tkt/Tpi1,2
BP,GO:0071450,cellular response to oxygen radical,2/85,18/23355,0.001928401,0.014205181,0.009889236,Prdx1/Prdx2,2
BP,GO:0071451,cellular response to superoxide,2/85,18/23355,0.001928401,0.014205181,0.009889236,Prdx1/Prdx2,2
BP,GO:1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,2/85,18/23355,0.001928401,0.014205181,0.009889236,Gpx1/Ppia,2
BP,GO:0043624,cellular protein complex disassembly,4/85,145/23355,0.001955085,0.014349182,0.009989485,Cfl1/Eif5a/Spta1/Sptb,4
BP,GO:2000378,negative regulation of reactive oxygen species metabolic process,3/85,70/23355,0.002136146,0.0156102,0.010867369,Eef1a1/Hp/Rhoa,3
BP,GO:0006089,lactate metabolic process,2/85,19/23355,0.002150187,0.0156102,0.010867369,Glo1/Ldha,2
BP,GO:0010544,negative regulation of platelet activation,2/85,19/23355,0.002150187,0.0156102,0.010867369,Fgg/Gp5,2
BP,GO:1903522,regulation of blood circulation,5/85,249/23355,0.002170184,0.015698703,0.010928983,Fga/Fgb/Fgg/Pebp1/Rhoa,5
BP,GO:0002687,positive regulation of leukocyte migration,4/85,151/23355,0.002265562,0.016329913,0.011368413,Lbp/Rhoa/Thbs1/Thbs4,4
BP,GO:0034101,erythrocyte homeostasis,4/85,153/23355,0.002376185,0.016700837,0.01162664,Ank1/Bpgm/Prdx1/Slc4a1,4
BP,GO:0009163,nucleoside biosynthetic process,2/85,20/23355,0.002383461,0.016700837,0.01162664,Nme1/Pnp,2
BP,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,2/85,20/23355,0.002383461,0.016700837,0.01162664,Ltf/Prdx2,2
BP,GO:0042451,purine nucleoside biosynthetic process,2/85,20/23355,0.002383461,0.016700837,0.01162664,Nme1/Pnp,2
BP,GO:0042454,ribonucleoside catabolic process,2/85,20/23355,0.002383461,0.016700837,0.01162664,Gda/Pnp,2
BP,GO:0042455,ribonucleoside biosynthetic process,2/85,20/23355,0.002383461,0.016700837,0.01162664,Nme1/Pnp,2
BP,GO:0046129,purine ribonucleoside biosynthetic process,2/85,20/23355,0.002383461,0.016700837,0.01162664,Nme1/Pnp,2
BP,GO:1990776,response to angiotensin,2/85,20/23355,0.002383461,0.016700837,0.01162664,Car2/Capn1,2
BP,GO:0010634,positive regulation of epithelial cell migration,4/85,155/23355,0.002490475,0.017390089,0.012106477,Enpp2/Flt4/Pfn1/Thbs1,4
BP,GO:0050714,positive regulation of protein secretion,4/85,157/23355,0.002608493,0.017976834,0.012514951,Fga/Fgb/Fgg/Ppia,4
BP,GO:0000303,response to superoxide,2/85,21/23355,0.00262814,0.017976834,0.012514951,Prdx1/Prdx2,2
BP,GO:0009159,deoxyribonucleoside monophosphate catabolic process,2/85,21/23355,0.00262814,0.017976834,0.012514951,Gda/Pnp,2
BP,GO:0030194,positive regulation of blood coagulation,2/85,21/23355,0.00262814,0.017976834,0.012514951,Prdx2/Thbs1,2
BP,GO:0034143,regulation of toll-like receptor 4 signaling pathway,2/85,21/23355,0.00262814,0.017976834,0.012514951,Lbp/Ltf,2
BP,GO:1900048,positive regulation of hemostasis,2/85,21/23355,0.00262814,0.017976834,0.012514951,Prdx2/Thbs1,2
BP,GO:0050807,regulation of synapse organization,5/85,261/23355,0.002659563,0.018130106,0.012621655,Cfl1/Rhoa/Snca/Srgn/Vcp,5
BP,GO:0009142,nucleoside triphosphate biosynthetic process,3/85,77/23355,0.002802889,0.019042599,0.013256906,Nme1/Pnp/Vcp,3
BP,GO:0009151,purine deoxyribonucleotide metabolic process,2/85,22/23355,0.002884139,0.019398002,0.013504328,Gda/Pnp,2
BP,GO:0009158,ribonucleoside monophosphate catabolic process,2/85,22/23355,0.002884139,0.019398002,0.013504328,Gda/Pnp,2
BP,GO:0010666,positive regulation of cardiac muscle cell apoptotic process,2/85,22/23355,0.002884139,0.019398002,0.013504328,Capn1/Eif5a,2
BP,GO:1901292,nucleoside phosphate catabolic process,3/85,78/23355,0.002907411,0.019489342,0.013567916,Gda/Pnp/Vcp,3
BP,GO:0043154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,3/85,80/23355,0.00312359,0.020710498,0.01441805,Gpx1/Snca/Thbs1,3
BP,GO:0009164,nucleoside catabolic process,2/85,23/23355,0.003151374,0.020710498,0.01441805,Gda/Pnp,2
BP,GO:0010663,positive regulation of striated muscle cell apoptotic process,2/85,23/23355,0.003151374,0.020710498,0.01441805,Capn1/Eif5a,2
BP,GO:0051156,glucose 6-phosphate metabolic process,2/85,23/23355,0.003151374,0.020710498,0.01441805,Rpia/Tkt,2
BP,GO:1901659,glycosyl compound biosynthetic process,2/85,23/23355,0.003151374,0.020710498,0.01441805,Nme1/Pnp,2
BP,GO:1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,2/85,23/23355,0.003151374,0.020710498,0.01441805,Capn1/Rhoa,2
BP,GO:0050803,regulation of synapse structure or activity,5/85,273/23355,0.003224544,0.021055506,0.014658234,Cfl1/Rhoa/Snca/Srgn/Vcp,5
BP,GO:1900542,regulation of purine nucleotide metabolic process,3/85,81/23355,0.003235282,0.021055506,0.014658234,Slc4a1/Snca/Vcp,3
BP,GO:1901880,negative regulation of protein depolymerization,3/85,81/23355,0.003235282,0.021055506,0.014658234,Cfl1/Spta1/Sptb,3
BP,GO:1903706,regulation of hemopoiesis,6/85,396/23355,0.003245891,0.021056412,0.014658864,Car2/Nme1/Pf4/Pnp/Prdx2/Rhoa,6
BP,GO:0032680,regulation of tumor necrosis factor production,4/85,168/23355,0.003326893,0.02145108,0.014933621,Lbp/Ltf/Pf4/Thbs1,4
BP,GO:0006140,regulation of nucleotide metabolic process,3/85,82/23355,0.003349398,0.02145108,0.014933621,Slc4a1/Snca/Vcp,3
BP,GO:0034103,regulation of tissue remodeling,3/85,82/23355,0.003349398,0.02145108,0.014933621,Car2/Flt4/Thbs4,3
BP,GO:0051817,modulation of process of other organism involved in symbiotic interaction,3/85,82/23355,0.003349398,0.02145108,0.014933621,Cfl1/Ltf/Stom,3
BP,GO:0002523,leukocyte migration involved in inflammatory response,2/85,24/23355,0.003429762,0.021757891,0.015147214,Lbp/Ppbp,2
BP,GO:0006516,glycoprotein catabolic process,2/85,24/23355,0.003429762,0.021757891,0.015147214,Cela1/Cst3,2
BP,GO:0050820,positive regulation of coagulation,2/85,24/23355,0.003429762,0.021757891,0.015147214,Prdx2/Thbs1,2
BP,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,4/85,170/23355,0.003470592,0.021947673,0.015279335,Lbp/Ltf/Pf4/Thbs1,4
BP,GO:0050792,regulation of viral process,4/85,171/23355,0.003544002,0.022271835,0.015505007,Ltf/Pfn1/Ppia/Stom,4
BP,GO:0071674,mononuclear cell migration,4/85,171/23355,0.003544002,0.022271835,0.015505007,Ccl8/Retnlg/Rhoa/Thbs1,4
BP,GO:0061515,myeloid cell development,3/85,84/23355,0.003584969,0.022459103,0.015635377,Ank1/Bpgm/Slc4a1,3
BP,GO:0051346,negative regulation of hydrolase activity,6/85,405/23355,0.003622882,0.022626139,0.015751663,Cst3/Gpx1/Ltf/Pebp1/Snca/Thbs1,6
BP,GO:0046685,response to arsenic-containing substance,2/85,25/23355,0.003719221,0.023084423,0.016070707,Slc4a1/Vcp,2
BP,GO:0048266,behavioral response to pain,2/85,25/23355,0.003719221,0.023084423,0.016070707,Thbs1/Thbs4,2
BP,GO:0032640,tumor necrosis factor production,4/85,174/23355,0.003770559,0.023331058,0.016242407,Lbp/Ltf/Pf4/Thbs1,4
BP,GO:0071706,tumor necrosis factor superfamily cytokine production,4/85,177/23355,0.004006757,0.024570066,0.017104969,Lbp/Ltf/Pf4/Thbs1,4
BP,GO:0009125,nucleoside monophosphate catabolic process,2/85,26/23355,0.004019668,0.024570066,0.017104969,Gda/Pnp,2
BP,GO:0009162,deoxyribonucleoside monophosphate metabolic process,2/85,26/23355,0.004019668,0.024570066,0.017104969,Gda/Pnp,2
BP,GO:0034656,nucleobase-containing small molecule catabolic process,2/85,26/23355,0.004019668,0.024570066,0.017104969,Gda/Pnp,2
BP,GO:1902107,positive regulation of leukocyte differentiation,4/85,178/23355,0.004087665,0.024834727,0.017289218,Car2/Pf4/Pnp/Rhoa,4
BP,GO:1903708,positive regulation of hemopoiesis,4/85,178/23355,0.004087665,0.024834727,0.017289218,Car2/Pf4/Pnp/Rhoa,4
BP,GO:0010951,negative regulation of endopeptidase activity,4/85,179/23355,0.004169673,0.025256662,0.017582957,Gpx1/Ltf/Snca/Thbs1,4
BP,GO:0002253,activation of immune response,6/85,420/23355,0.004322446,0.025768292,0.017939139,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
BP,GO:0045730,respiratory burst,2/85,27/23355,0.004331021,0.025768292,0.017939139,Lbp/Prdx2,2
BP,GO:0046386,deoxyribose phosphate catabolic process,2/85,27/23355,0.004331021,0.025768292,0.017939139,Gda/Pnp,2
BP,GO:0051894,positive regulation of focal adhesion assembly,2/85,27/23355,0.004331021,0.025768292,0.017939139,Cfl1/Enpp2,2
BP,GO:0090023,positive regulation of neutrophil chemotaxis,2/85,27/23355,0.004331021,0.025768292,0.017939139,Lbp/Thbs4,2
BP,GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,2/85,27/23355,0.004331021,0.025768292,0.017939139,Gpx1/Ppia,2
BP,GO:0051341,regulation of oxidoreductase activity,3/85,90/23355,0.004351533,0.025813962,0.017970934,Hp/Slc4a1/Snca,3
BP,GO:0043242,negative regulation of protein-containing complex disassembly,3/85,91/23355,0.004488182,0.026546277,0.01848075,Cfl1/Spta1/Sptb,3
BP,GO:0043903,regulation of biological process involved in symbiotic interaction,4/85,184/23355,0.004596444,0.027106888,0.018871031,Ltf/Pfn1/Ppia/Stom,4
BP,GO:1903578,regulation of ATP metabolic process,3/85,92/23355,0.004627409,0.027202273,0.018937435,Rhoa/Slc4a1/Vcp,3
BP,GO:0009264,deoxyribonucleotide catabolic process,2/85,28/23355,0.004653198,0.027202273,0.018937435,Gda/Pnp,2
BP,GO:0033688,regulation of osteoblast proliferation,2/85,28/23355,0.004653198,0.027202273,0.018937435,Ltf/Rhoa,2
BP,GO:0071900,regulation of protein serine/threonine kinase activity,6/85,427/23355,0.004681114,0.027286144,0.018995824,Ltf/Ppia/Prdx2/Rhoa/Snca/Thbs1,6
BP,GO:0055072,iron ion homeostasis,3/85,93/23355,0.004769229,0.027673502,0.019265492,Ank1/Ftl1/Ltf,3
BP,GO:0002793,positive regulation of peptide secretion,4/85,186/23355,0.00477509,0.027673502,0.019265492,Fga/Fgb/Fgg/Ppia,4
BP,GO:1901222,regulation of NIK/NF-kappaB signaling,3/85,94/23355,0.004913654,0.028325105,0.019719118,Capn1/Prdx1/Rhoa,3
BP,GO:0002082,regulation of oxidative phosphorylation,2/85,29/23355,0.00498612,0.028325105,0.019719118,Rhoa/Vcp,2
BP,GO:0034123,positive regulation of toll-like receptor signaling pathway,2/85,29/23355,0.00498612,0.028325105,0.019719118,Lbp/Ltf,2
BP,GO:0043032,positive regulation of macrophage activation,2/85,29/23355,0.00498612,0.028325105,0.019719118,Lbp/Thbs1,2
BP,GO:0045109,intermediate filament organization,2/85,29/23355,0.00498612,0.028325105,0.019719118,Krt14/Krt6a,2
BP,GO:0071624,positive regulation of granulocyte chemotaxis,2/85,29/23355,0.00498612,0.028325105,0.019719118,Lbp/Thbs4,2
BP,GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,2/85,29/23355,0.00498612,0.028325105,0.019719118,Capn1/Rhoa,2
BP,GO:0002690,positive regulation of leukocyte chemotaxis,3/85,95/23355,0.005060699,0.028587263,0.019901625,Lbp/Thbs1/Thbs4,3
BP,GO:1901879,regulation of protein depolymerization,3/85,95/23355,0.005060699,0.028587263,0.019901625,Cfl1/Spta1/Sptb,3
BP,GO:0031346,positive regulation of cell projection organization,6/85,436/23355,0.005173994,0.029145385,0.020290174,Cfl1/Eef1a1/Enpp2/Gdi1/Nme1/Pfn1,6
BP,GO:0070555,response to interleukin-1,3/85,96/23355,0.005210377,0.029268344,0.020375774,Ccl8/Cfl1/Snca,3
BP,GO:0002262,myeloid cell homeostasis,4/85,192/23355,0.005338944,0.029865983,0.020791833,Ank1/Bpgm/Prdx1/Slc4a1,4
BP,GO:0045860,positive regulation of protein kinase activity,6/85,439/23355,0.005346471,0.029865983,0.020791833,Ltf/Ppia/Prdx2/Rhoa/Snca/Thbs1,6
BP,GO:0051222,positive regulation of protein transport,5/85,309/23355,0.005436392,0.030284167,0.02108296,Fga/Fgb/Fgg/Ppia/Stom,5
BP,GO:0050673,epithelial cell proliferation,6/85,443/23355,0.005582969,0.031014782,0.021591594,Flt4/Gpx1/Igfbp4/Nme1/Thbs1/Thbs4,6
BP,GO:0070372,regulation of ERK1 and ERK2 cascade,5/85,312/23355,0.00565933,0.031315799,0.021801153,Ccl8/Fga/Fgb/Fgg/Flt4,5
BP,GO:0006734,NADH metabolic process,2/85,31/23355,0.005683872,0.031315799,0.021801153,Ldha/Vcp,2
BP,GO:1901658,glycosyl compound catabolic process,2/85,31/23355,0.005683872,0.031315799,0.021801153,Gda/Pnp,2
BP,GO:0007015,actin filament organization,6/85,445/23355,0.005704056,0.031341136,0.021818792,Capn1/Cfl1/Pfn1/Rhoa/Spta1/Sptb,6
BP,GO:0051099,positive regulation of binding,4/85,196/23355,0.00573864,0.031445247,0.021891271,Eno1/Epb41/Nme1/Spta1,4
BP,GO:0042102,positive regulation of T cell proliferation,3/85,100/23355,0.00583567,0.031749877,0.022103345,Pnp/Slc4a1/Spta1,3
BP,GO:0042116,macrophage activation,3/85,100/23355,0.00583567,0.031749877,0.022103345,Lbp/Snca/Thbs1,3
BP,GO:0030307,positive regulation of cell growth,4/85,197/23355,0.005841598,0.031749877,0.022103345,Cfl1/Flt4/Gdi1/Rhoa,4
BP,GO:0046475,glycerophospholipid catabolic process,2/85,32/23355,0.006048543,0.03261024,0.022702306,Enpp2/Prdx6,2
BP,GO:0150117,positive regulation of cell-substrate junction organization,2/85,32/23355,0.006048543,0.03261024,0.022702306,Cfl1/Enpp2,2
BP,GO:1903579,negative regulation of ATP metabolic process,2/85,32/23355,0.006048543,0.03261024,0.022702306,Rhoa/Slc4a1,2
BP,GO:0032760,positive regulation of tumor necrosis factor production,3/85,102/23355,0.00616444,0.033146226,0.023075444,Lbp/Pf4/Thbs1,3
BP,GO:0050870,positive regulation of T cell activation,4/85,201/23355,0.006265759,0.033601177,0.023392167,Pnp/Rhoa/Slc4a1/Spta1,4
BP,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,3/85,103/23355,0.006332897,0.033870892,0.023579935,Lbp/Pf4/Thbs1,3
BP,GO:0033687,osteoblast proliferation,2/85,33/23355,0.006423638,0.034084262,0.023728477,Ltf/Rhoa,2
BP,GO:1901099,negative regulation of signal transduction in absence of ligand,2/85,33/23355,0.006423638,0.034084262,0.023728477,Pf4/Prdx2,2
BP,GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,2/85,33/23355,0.006423638,0.034084262,0.023728477,Pf4/Prdx2,2
BP,GO:1902905,positive regulation of supramolecular fiber organization,4/85,203/23355,0.006485324,0.034321019,0.0238933,Cfl1/Gda/Pfn1/Rhoa,4
BP,GO:0019731,antibacterial humoral response,3/85,104/23355,0.006504084,0.034329954,0.02389952,Fga/Fgb/Ltf,3
BP,GO:0050863,regulation of T cell activation,5/85,323/23355,0.006532198,0.03438809,0.023939993,Pnp/Prdx2/Rhoa/Slc4a1/Spta1,5
BP,GO:1904951,positive regulation of establishment of protein localization,5/85,325/23355,0.006700503,0.035139847,0.024463345,Fga/Fgb/Fgg/Ppia/Stom,5
BP,GO:0001906,cell killing,4/85,205/23355,0.006709946,0.035139847,0.024463345,Ltf/Pf4/Pnp/Prdx1,4
BP,GO:0043537,negative regulation of blood vessel endothelial cell migration,2/85,34/23355,0.006809077,0.035474235,0.024696136,Rhoa/Thbs1,2
BP,GO:0090022,regulation of neutrophil chemotaxis,2/85,34/23355,0.006809077,0.035474235,0.024696136,Lbp/Thbs4,2
BP,GO:0006119,oxidative phosphorylation,3/85,107/23355,0.007034134,0.036552049,0.025446479,Rhoa/Snca/Vcp,3
BP,GO:0009154,purine ribonucleotide catabolic process,2/85,35/23355,0.007204784,0.037055807,0.02579718,Gda/Pnp,2
BP,GO:0030808,regulation of nucleotide biosynthetic process,2/85,35/23355,0.007204784,0.037055807,0.02579718,Snca/Vcp,2
BP,GO:0043243,positive regulation of protein-containing complex disassembly,2/85,35/23355,0.007204784,0.037055807,0.02579718,Cfl1/Eif5a,2
BP,GO:1900371,regulation of purine nucleotide biosynthetic process,2/85,35/23355,0.007204784,0.037055807,0.02579718,Snca/Vcp,2
BP,GO:0070371,ERK1 and ERK2 cascade,5/85,332/23355,0.007313567,0.037519343,0.026119881,Ccl8/Fga/Fgb/Fgg/Flt4,5
BP,GO:0090313,regulation of protein targeting to membrane,2/85,36/23355,0.007610679,0.038747027,0.026974559,Gdi1/Stom,2
BP,GO:1902624,positive regulation of neutrophil migration,2/85,36/23355,0.007610679,0.038747027,0.026974559,Lbp/Thbs4,2
BP,GO:1902745,positive regulation of lamellipodium organization,2/85,36/23355,0.007610679,0.038747027,0.026974559,Cfl1/Enpp2,2
BP,GO:0032231,regulation of actin filament bundle assembly,3/85,111/23355,0.007779734,0.039408172,0.027434829,Cfl1/Pfn1/Rhoa,3
BP,GO:2000379,positive regulation of reactive oxygen species metabolic process,3/85,111/23355,0.007779734,0.039408172,0.027434829,Eif5a/Snca/Thbs1,3
BP,GO:0042098,T cell proliferation,4/85,215/23355,0.007910596,0.039970373,0.027826217,Pnp/Prdx2/Slc4a1/Spta1,4
BP,GO:0002526,acute inflammatory response,3/85,112/23355,0.007973141,0.040185428,0.027975932,Hp/Ighg2b/Lbp,3
BP,GO:0032232,negative regulation of actin filament bundle assembly,2/85,37/23355,0.008026685,0.040209545,0.027992722,Cfl1/Pfn1,2
BP,GO:0033238,regulation of cellular amine metabolic process,2/85,37/23355,0.008026685,0.040209545,0.027992722,Pebp1/Snca,2
BP,GO:0051651,maintenance of location in cell,4/85,216/23355,0.00803791,0.040209545,0.027992722,Ftl1/Pfn1/Snca/Srgn,4
BP,GO:0014812,muscle cell migration,3/85,113/23355,0.008169369,0.040664855,0.028309695,Fga/Rhoa/Thbs4,3
BP,GO:0038061,NIK/NF-kappaB signaling,3/85,113/23355,0.008169369,0.040664855,0.028309695,Capn1/Prdx1/Rhoa,3
BP,GO:0043542,endothelial cell migration,4/85,218/23355,0.008296568,0.041196044,0.028679493,Flt4/Gpx1/Rhoa/Thbs1,4
BP,GO:0001953,negative regulation of cell-matrix adhesion,2/85,38/23355,0.008452725,0.041358711,0.028792737,Enpp2/Thbs1,2
BP,GO:0010543,regulation of platelet activation,2/85,38/23355,0.008452725,0.041358711,0.028792737,Fgg/Gp5,2
BP,GO:0010661,positive regulation of muscle cell apoptotic process,2/85,38/23355,0.008452725,0.041358711,0.028792737,Capn1/Eif5a,2
BP,GO:0034142,toll-like receptor 4 signaling pathway,2/85,38/23355,0.008452725,0.041358711,0.028792737,Lbp/Ltf,2
BP,GO:0048265,response to pain,2/85,38/23355,0.008452725,0.041358711,0.028792737,Thbs1/Thbs4,2
BP,GO:1903427,negative regulation of reactive oxygen species biosynthetic process,2/85,38/23355,0.008452725,0.041358711,0.028792737,Eef1a1/Rhoa,2
BP,GO:0050808,synapse organization,6/85,486/23355,0.008633301,0.042132688,0.029331558,Cfl1/Pfn1/Rhoa/Snca/Srgn/Vcp,6
BP,GO:1903532,positive regulation of secretion by cell,5/85,346/23355,0.008655522,0.042132688,0.029331558,Fga/Fgb/Fgg/Ppia/Snca,5
BP,GO:0010810,regulation of cell-substrate adhesion,4/85,221/23355,0.008694712,0.042132688,0.029331558,Cfl1/Enpp2/Rhoa/Thbs1,4
BP,GO:0051495,positive regulation of cytoskeleton organization,4/85,221/23355,0.008694712,0.042132688,0.029331558,Cfl1/Gda/Pfn1/Rhoa,4
BP,GO:0002861,regulation of inflammatory response to antigenic stimulus,2/85,39/23355,0.008888722,0.042661623,0.029699787,Gpx1/Ighg2b,2
BP,GO:0006195,purine nucleotide catabolic process,2/85,39/23355,0.008888722,0.042661623,0.029699787,Gda/Pnp,2
BP,GO:0006739,NADP metabolic process,2/85,39/23355,0.008888722,0.042661623,0.029699787,Rpia/Tkt,2
BP,GO:0090049,regulation of cell migration involved in sprouting angiogenesis,2/85,39/23355,0.008888722,0.042661623,0.029699787,Rhoa/Thbs1,2
BP,GO:0007009,plasma membrane organization,3/85,117/23355,0.008982681,0.04300993,0.029942269,Slc4a1/Spta1/Sptb,3
BP,GO:0007052,mitotic spindle organization,3/85,118/23355,0.00919315,0.043913125,0.030571047,Kpnb1/Rhoa/Vcp,3
BP,GO:0002573,myeloid leukocyte differentiation,4/85,225/23355,0.009244764,0.044055027,0.030669835,Car2/Glo1/Nme1/Pf4,4
BP,GO:0006730,one-carbon metabolic process,2/85,40/23355,0.0093346,0.044377967,0.030894656,Car1/Car2,2
BP,GO:0000187,activation of MAPK activity,3/85,119/23355,0.009406494,0.044509315,0.030986097,Ppia/Prdx2/Thbs1,3
BP,GO:0043534,blood vessel endothelial cell migration,3/85,119/23355,0.009406494,0.044509315,0.030986097,Gpx1/Rhoa/Thbs1,3
BP,GO:0009394,2'-deoxyribonucleotide metabolic process,2/85,41/23355,0.009790282,0.046000601,0.032024287,Gda/Pnp,2
BP,GO:0019692,deoxyribose phosphate metabolic process,2/85,41/23355,0.009790282,0.046000601,0.032024287,Gda/Pnp,2
BP,GO:0071364,cellular response to epidermal growth factor stimulus,2/85,41/23355,0.009790282,0.046000601,0.032024287,Cfl1/Eef1a1,2
BP,GO:0002688,regulation of leukocyte chemotaxis,3/85,121/23355,0.009841831,0.046135017,0.032117863,Lbp/Thbs1/Thbs4,3
BP,GO:0019058,viral life cycle,4/85,231/23355,0.010111674,0.047289711,0.032921728,Ltf/Ppia/Stom/Vcp,4
BP,GO:0006953,acute-phase response,2/85,42/23355,0.010255694,0.047784487,0.033266177,Hp/Lbp,2
BP,GO:0001952,regulation of cell-matrix adhesion,3/85,123/23355,0.010288753,0.047784487,0.033266177,Cfl1/Enpp2/Thbs1,3
BP,GO:0090277,positive regulation of peptide hormone secretion,3/85,123/23355,0.010288753,0.047784487,0.033266177,Fga/Fgb/Fgg,3
BP,GO:0002040,sprouting angiogenesis,3/85,124/23355,0.010516577,0.048618013,0.033846454,Flt4/Rhoa/Thbs1,3
BP,GO:0051261,protein depolymerization,3/85,124/23355,0.010516577,0.048618013,0.033846454,Cfl1/Spta1/Sptb,3
BP,GO:0062208,positive regulation of pattern recognition receptor signaling pathway,2/85,43/23355,0.01073076,0.049381139,0.03437772,Lbp/Ltf,2
BP,GO:0072523,purine-containing compound catabolic process,2/85,43/23355,0.01073076,0.049381139,0.03437772,Gda/Pnp,2
CC,GO:0005938,cell cortex,14/86,306/23177,7.03E-12,1.12E-09,8.21E-10,Ank1/Cfl1/Eef1a1/Eno1/Epb41/Fga/Fgb/Fgg/Pfn1/Rhoa/Slc4a1/Snca/Spta1/Sptb,14
CC,GO:0031091,platelet alpha granule,6/86,19/23177,5.71E-11,4.54E-09,3.33E-09,Fga/Fgb/Fgg/Pf4/Snca/Thbs1,6
CC,GO:0043209,myelin sheath,11/86,213/23177,4.08E-10,2.16E-08,1.59E-08,Car2/Eef1a1/Eno1/Gdi1/Nme1/Pebp1/Ppia/Prdx1/Prdx2/Tkt/Vcp,11
CC,GO:0072562,blood microparticle,4/86,10/23177,3.65E-08,1.45E-06,1.07E-06,Fga/Fgb/Fgg/Hp,4
CC,GO:0030863,cortical cytoskeleton,7/86,123/23177,3.79E-07,1.21E-05,8.86E-06,Ank1/Cfl1/Eef1a1/Epb41/Slc4a1/Spta1/Sptb,7
CC,GO:0062023,collagen-containing extracellular matrix,10/86,386/23177,1.68E-06,4.45E-05,3.27E-05,Cela1/Cst3/Fga/Fgb/Fgg/Mmrn1/Pf4/Thbs1/Thbs4/Vwf,10
CC,GO:0042571,"immunoglobulin complex, circulating",6/86,138/23177,1.27E-05,0.000288599,0.000212078,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
CC,GO:0019814,immunoglobulin complex,6/86,142/23177,1.50E-05,0.000297162,0.000218371,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
CC,GO:0031838,haptoglobin-hemoglobin complex,3/86,14/23177,1.74E-05,0.000304143,0.000223502,Hbb-bs/Hbq1b/Hp,3
CC,GO:0030141,secretory granule,9/86,404/23177,1.91E-05,0.000304143,0.000223502,Fga/Fgb/Fgg/Ltf/Pf4/Snca/Srgn/Thbs1/Vwf,9
CC,GO:0009898,cytoplasmic side of plasma membrane,6/86,172/23177,4.40E-05,0.000636609,0.000467816,Acp1/Ank1/Epb41/Rhoa/Slc4a1/Spta1,6
CC,GO:0098562,cytoplasmic side of membrane,6/86,189/23177,7.43E-05,0.000984889,0.000723751,Acp1/Ank1/Epb41/Rhoa/Slc4a1/Spta1,6
CC,GO:0030864,cortical actin cytoskeleton,4/86,87/23177,0.000311051,0.003804388,0.002795677,Cfl1/Eef1a1/Spta1/Sptb,4
CC,GO:0005791,rough endoplasmic reticulum,4/86,90/23177,0.000354065,0.004021165,0.002954977,Fga/Pebp1/Snca/Uba1,4
CC,GO:0005833,hemoglobin complex,2/86,13/23177,0.001033652,0.010956709,0.008051604,Hbb-bs/Hbq1b,2
CC,GO:0032587,ruffle membrane,3/86,69/23177,0.002165882,0.02152345,0.015816637,Eef1a1/Nme1/Rhoa,3
CC,GO:0031256,leading edge membrane,4/86,150/23177,0.002372381,0.022188739,0.016305528,Ank1/Eef1a1/Nme1/Rhoa,4
CC,GO:0016529,sarcoplasmic reticulum,3/86,75/23177,0.00274714,0.024266399,0.017832309,Ank1/Thbs1/Thbs4,3
CC,GO:0016528,sarcoplasm,3/86,84/23177,0.003784798,0.031672786,0.023274937,Ank1/Thbs1/Thbs4,3
MF,GO:0016209,antioxidant activity,8/82,83/22682,6.51E-10,1.73E-07,1.16E-07,Gpx1/Hbb-bs/Hbq1b/Hp/Prdx1/Prdx2/Prdx6/Txnrd2,8
MF,GO:0004601,peroxidase activity,6/82,54/22682,4.17E-08,5.54E-06,3.71E-06,Gpx1/Hbb-bs/Hbq1b/Prdx1/Prdx2/Prdx6,6
MF,GO:0016684,"oxidoreductase activity, acting on peroxide as acceptor",6/82,58/22682,6.46E-08,5.73E-06,3.83E-06,Gpx1/Hbb-bs/Hbq1b/Prdx1/Prdx2/Prdx6,6
MF,GO:0005201,extracellular matrix structural constituent,7/82,150/22682,1.21E-06,8.03E-05,5.37E-05,Fga/Fgb/Fgg/Mmrn1/Thbs1/Thbs4/Vwf,7
MF,GO:0005518,collagen binding,5/82,71/22682,5.89E-06,0.000313554,0.000209698,Gp5/Srgn/Thbs1/Thbs4/Vwf,5
MF,GO:0030492,hemoglobin binding,3/82,13/22682,1.27E-05,0.000487358,0.000325934,Hbb-bs/Hp/Slc4a1,3
MF,GO:0034987,immunoglobulin receptor binding,6/82,142/22682,1.28E-05,0.000487358,0.000325934,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
MF,GO:0005092,GDP-dissociation inhibitor activity,3/82,16/22682,2.47E-05,0.000819644,0.000548159,Arhgdia/Eif5/Gdi1,3
MF,GO:1901681,sulfur compound binding,7/82,265/22682,4.95E-05,0.00146191,0.000977692,Ccl8/Ltf/Pf4/Ppia/Thbs1/Thbs4/Tkt,7
MF,GO:0050839,cell adhesion molecule binding,7/82,287/22682,8.16E-05,0.002171132,0.001452003,Fga/Fgb/Fgg/Ppia/Thbs1/Thbs4/Vwf,7
MF,GO:0016835,carbon-oxygen lyase activity,4/82,68/22682,0.000108354,0.002405379,0.001608663,Car1/Car2/Eno1/Tpi1,4
MF,GO:0003823,antigen binding,6/82,208/22682,0.000108513,0.002405379,0.001608663,Ighg2b/Ighv14-1/Ighv1-62-2/Ighv1-62-3/Ighv1-81/Ighv9-1,6
MF,GO:0005539,glycosaminoglycan binding,6/82,217/22682,0.000136772,0.002798575,0.001871623,Ccl8/Ltf/Pf4/Ppia/Thbs1/Thbs4,6
MF,GO:0008201,heparin binding,5/82,159/22682,0.000280726,0.00533379,0.003567117,Ccl8/Ltf/Pf4/Thbs1/Thbs4,5
MF,GO:0052689,carboxylic ester hydrolase activity,5/82,164/22682,0.000323786,0.005741798,0.003839984,Car1/Car2/Enpp2/Esd/Prdx6,5
MF,GO:0008009,chemokine activity,3/82,42/22682,0.000472232,0.007850851,0.00525047,Ccl8/Pf4/Ppbp,3
MF,GO:0004252,serine-type endopeptidase activity,5/82,186/22682,0.00057536,0.009002686,0.006020791,Apeh/Cela1/F9/Hp/Ltf,5
MF,GO:0016829,lyase activity,5/82,191/22682,0.000648731,0.009586804,0.006411436,Car1/Car2/Eno1/Glo1/Tpi1,5
MF,GO:0008236,serine-type peptidase activity,5/82,207/22682,0.000931177,0.012523621,0.008375512,Apeh/Cela1/F9/Hp/Ltf,5
MF,GO:0031720,haptoglobin binding,2/82,13/22682,0.000981335,0.012523621,0.008375512,Hbb-bs/Hbq1b,2
MF,GO:0003779,actin binding,7/82,437/22682,0.001030596,0.012523621,0.008375512,Cfl1/Epb41/Pfn1/Slc4a1/Snca/Spta1/Sptb,7
MF,GO:0017171,serine hydrolase activity,5/82,212/22682,0.001035788,0.012523621,0.008375512,Apeh/Cela1/F9/Hp/Ltf,5
MF,GO:0016836,hydro-lyase activity,3/82,57/22682,0.001157598,0.012953625,0.008663089,Car1/Car2/Eno1,3
MF,GO:0047485,protein N-terminus binding,4/82,130/22682,0.001275668,0.012953625,0.008663089,Eif5a/Epb41/Snca/Vwf,4
MF,GO:0004089,carbonate dehydratase activity,2/82,15/22682,0.001314842,0.012953625,0.008663089,Car1/Car2,2
MF,GO:0019215,intermediate filament binding,2/82,15/22682,0.001314842,0.012953625,0.008663089,Krt14/Nme1,2
MF,GO:0045236,CXCR chemokine receptor binding,2/82,15/22682,0.001314842,0.012953625,0.008663089,Pf4/Ppbp,2
MF,GO:0005178,integrin binding,4/82,138/22682,0.001589257,0.015097946,0.010097162,Ppia/Thbs1/Thbs4/Vwf,4
MF,GO:0003746,translation elongation factor activity,2/82,17/22682,0.001695061,0.015547802,0.010398016,Eef1a1/Eif5a,2
MF,GO:0004869,cysteine-type endopeptidase inhibitor activity,3/82,68/22682,0.001926941,0.016757118,0.011206778,Cst3/Ltf/Snca,3
MF,GO:0031072,heat shock protein binding,4/82,146/22682,0.001952897,0.016757118,0.011206778,Arhgdia/Eno1/Kpnb1/Snca,4
MF,GO:0016853,isomerase activity,4/82,153/22682,0.002315207,0.019245154,0.01287072,Bpgm/Ppia/Rpia/Tpi1,4
MF,GO:0061134,peptidase regulator activity,5/82,258/22682,0.002451536,0.019562633,0.013083043,Cst3/Ltf/Pebp1/Snca/Vcp,5
MF,GO:0004602,glutathione peroxidase activity,2/82,21/22682,0.002592947,0.019562633,0.013083043,Gpx1/Prdx6,2
MF,GO:0008135,"translation factor activity, RNA binding",3/82,76/22682,0.002647574,0.019562633,0.013083043,Eef1a1/Eif5/Eif5a,3
MF,GO:0042379,chemokine receptor binding,3/82,76/22682,0.002647574,0.019562633,0.013083043,Ccl8/Pf4/Ppbp,3
MF,GO:0030506,ankyrin binding,2/82,23/22682,0.003109284,0.022353233,0.014949333,Slc4a1/Sptb,2
MF,GO:0019903,protein phosphatase binding,4/82,178/22682,0.003984984,0.027894886,0.018655464,Ank1/Cfl1/Flt4/Vcp,4
MF,GO:0019825,oxygen binding,2/82,27/22682,0.004273478,0.029147309,0.019493056,Hbb-bs/Hbq1b,2
MF,GO:0016814,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines",2/82,29/22682,0.004920046,0.032199145,0.021534054,Atic/Gda,2
MF,GO:0090079,"translation regulator activity, nucleic acid binding",3/82,95/22682,0.004963026,0.032199145,0.021534054,Eef1a1/Eif5/Eif5a,3
MF,GO:0051020,GTPase binding,5/82,307/22682,0.005132359,0.032504942,0.021738564,Arhgdia/Eno1/Gdi1/Kpnb1/Pfn1,5
MF,GO:0001530,lipopolysaccharide binding,2/82,30/22682,0.00525917,0.032533472,0.021757644,Lbp/Ltf,2
MF,GO:0030507,spectrin binding,2/82,31/22682,0.005608749,0.033907438,0.022676522,Ank1/Epb41,2
MF,GO:0001968,fibronectin binding,2/82,32/22682,0.005968705,0.033916878,0.022682835,Thbs1/Thbs4,2
MF,GO:0043236,laminin binding,2/82,32/22682,0.005968705,0.033916878,0.022682835,Thbs1/Thbs4,2
MF,GO:0004175,endopeptidase activity,6/82,453/22682,0.005992832,0.033916878,0.022682835,Apeh/Capn1/Cela1/F9/Hp/Ltf,6
MF,GO:0051219,phosphoprotein binding,3/82,105/22682,0.006550446,0.036300389,0.024276873,Epb41/Pfn1/Snca,3
MF,GO:0008198,ferrous iron binding,2/82,35/22682,0.007110058,0.038597459,0.025813101,Ftl1/Snca,2
MF,GO:0004866,endopeptidase inhibitor activity,4/82,212/22682,0.007352828,0.039117045,0.026160588,Cst3/Ltf/Pebp1/Snca,4
MF,GO:0030414,peptidase inhibitor activity,4/82,219/22682,0.008223627,0.042891858,0.028685097,Cst3/Ltf/Pebp1/Snca,4
MF,GO:0019902,phosphatase binding,4/82,225/22682,0.009021848,0.045279464,0.030281874,Ank1/Cfl1/Flt4/Vcp,4
MF,GO:0061135,endopeptidase regulator activity,4/82,225/22682,0.009021848,0.045279464,0.030281874,Cst3/Ltf/Pebp1/Snca,4